Viewing nowCoroza Tablet 50 mg (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.

MFDS item code 200600688 · Notified 2006.02.28 · Insurance code 698500370
Treatment of hypertension and kidney disease in patients with type 2 diabetes accompanied by hypertension
This medication helps lower blood pressure in hypertensive patients, thereby reducing the risk of cardiovascular diseases. It is also used to protect kidney function in patients with hypertension among those with type 2 diabetes, thus slowing the progression of nephropathy. It is effectively utilized for the prevention and improvement of complications associated with hypertension.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Hypertension - Adults: The recommended initial and maintenance dose is losartan potassium 50 mg orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after the start of treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses daily or, if necessary, increased to 100 mg once daily. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). Elderly patients: No adjustment of the initial dose is necessary for elderly patients 75 years of age or younger. For patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Patients with renal impairment - Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Patients with renal impairment - Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. Patients with reduced intravascular effective blood volume: An initial dose of 25 mg of this medicine once daily is recommended for patients who may have reduced intravascular volume (e.g., patients receiving diuretic therapy) (see Precautions for Use). Patients with hepatic impairment: Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents 6 years of age and older who weigh 20 kg or more but less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily; it may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents 6 years of age and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily; it may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This medication can cause severe harm to the fetus if taken during pregnancy, especially in the second and third trimesters; therefore, it should not be used by pregnant women or those who may become pregnant. Patients with allergic reactions to this medication, severely impaired liver function, history of angioedema, or specific genetic disorders should not use this medication. Elderly patients, those with kidney dysfunction, and patients with hyperkalemia should use this medication with caution, as there is a risk of rapid drops in blood pressure, and their conditions should be closely monitored. Although this medication is generally safe to use, side effects such as muscle cramps, dizziness, and upper respiratory infections may occur, and in severe cases, serious adverse reactions like angioedema or renal failure may arise. During the administration of this medication, liver and kidney functions, as well as serum electrolyte levels, should be regularly monitored to ensure no abnormalities, especially regarding the potential occurrence of hyperkalemia. When taken in conjunction with other antihypertensive agents or potassium-sparing diuretics and potassium supplements, interactions may lead to hyperkalemia or worsening kidney function, so it is essential to consult a doctor. This medication is not recommended for nursing women, and if it must be taken, discontinuation of breastfeeding is advised. In cases of overdose, hypotension or cardiac arrhythmias may occur; therefore, adherence to dosage is essential, and immediate consultation with healthcare professionals is necessary should any abnormal symptoms arise. Dizziness may occur while driving or operating machinery during the use of this medication, so caution is advised, especially at the beginning of treatment or when dosage is adjusted.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture; therefore, it should be stored in a tightly sealed container. Additionally, avoid excessively hot or cold places, and store it at a temperature between 1 to 30 degrees Celsius.
White oval film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.